First Header Logo Second Header Logo

Connection

Gopal Badlani to Prostatic Hyperplasia

This is a "connection" page, showing publications Gopal Badlani has written about Prostatic Hyperplasia.
Connection Strength

2.793
  1. Peyton CC, Badlani GH. The management of prostatic obstruction with urethral stents. Can J Urol. 2015 Oct; 22 Suppl 1:75-81.
    View in: PubMed
    Score: 0.529
  2. Vanderbrink BA, Rastinehad AR, Badlani GH. Prostatic stents for the treatment of benign prostatic hyperplasia. Curr Opin Urol. 2007 Jan; 17(1):1-6.
    View in: PubMed
    Score: 0.289
  3. Eisenberg ER, Badlani GH. Long-term treatment outcomes of CoreTherm microwave feedback thermotherapy. Curr Urol Rep. 2004 Aug; 5(4):287-94.
    View in: PubMed
    Score: 0.244
  4. Kapoor R, Liatsikos EN, Badlani G. Endoprostatic stents for management of benign prostatic hyperplasia. Curr Opin Urol. 2000 Jan; 10(1):19-22.
    View in: PubMed
    Score: 0.178
  5. Bhojani N, Bidair M, Zorn KC, Trainer A, Arther A, Kramolowsky E, Doumanian L, Elterman D, Kaufman RP, Lingeman J, Krambeck A, Eure G, Badlani G, Plante M, Uchio E, Gin G, Goldenberg L, Paterson R, So A, Humphreys M, Kaplan S, Motola J, Desai M, Roehrborn C. Aquablation for Benign Prostatic Hyperplasia in Large Prostates (80-150 cc): 1-Year Results. Urology. 2019 Jul; 129:1-7.
    View in: PubMed
    Score: 0.170
  6. Gilling P, Barber N, Bidair M, Anderson P, Sutton M, Aho T, Kramolowsky E, Thomas A, Cowan B, Kaufman RP, Trainer A, Arther A, Badlani G, Plante M, Desai M, Doumanian L, Te AE, DeGuenther M, Roehrborn C. Two-Year Outcomes After Aquablation Compared to TURP: Efficacy and Ejaculatory Improvements Sustained. Adv Ther. 2019 06; 36(6):1326-1336.
    View in: PubMed
    Score: 0.169
  7. Desai M, Bidair M, Zorn KC, Trainer A, Arther A, Kramolowsky E, Doumanian L, Elterman D, Kaufman RP, Lingeman J, Krambeck A, Eure G, Badlani G, Plante M, Uchio E, Gin G, Goldenberg L, Paterson R, So A, Humphreys M, Roehrborn C, Kaplan S, Motola J, Bhojani N. Aquablation for benign prostatic hyperplasia in large prostates (80-150 mL): 6-month results from the WATER II trial. BJU Int. 2019 08; 124(2):321-328.
    View in: PubMed
    Score: 0.168
  8. Plante M, Gilling P, Barber N, Bidair M, Anderson P, Sutton M, Aho T, Kramolowsky E, Thomas A, Cowan B, Kaufman RP, Trainer A, Arther A, Badlani G, Desai M, Doumanian L, Te AE, DeGuenther M, Roehrborn C. Symptom relief and anejaculation after aquablation or transurethral resection of the prostate: subgroup analysis from a blinded randomized trial. BJU Int. 2019 04; 123(4):651-660.
    View in: PubMed
    Score: 0.161
  9. Desai M, Bidair M, Bhojani N, Trainer A, Arther A, Kramolowsky E, Doumanian L, Elterman D, Kaufman RP, Lingeman J, Krambeck A, Eure G, Badlani G, Plante M, Uchio E, Gin G, Goldenberg L, Paterson R, So A, Humphreys M, Roehrborn C, Kaplan S, Motola J, Zorn KC. WATER II (80-150 mL) procedural outcomes. BJU Int. 2019 01; 123(1):106-112.
    View in: PubMed
    Score: 0.159
  10. Gilling P, Barber N, Bidair M, Anderson P, Sutton M, Aho T, Kramolowsky E, Thomas A, Cowan B, Kaufman RP, Trainer A, Arther A, Badlani G, Plante M, Desai M, Doumanian L, Te AE, DeGuenther M, Roehrborn C. WATER: A Double-Blind, Randomized, Controlled Trial of Aquablation® vs Transurethral Resection of the Prostate in Benign Prostatic Hyperplasia. J Urol. 2018 05; 199(5):1252-1261.
    View in: PubMed
    Score: 0.156
  11. Hester AG, Kretschmer A, Badlani G. Male Incontinence: The Etiology or Basis of Treatment. Eur Urol Focus. 2017 10; 3(4-5):377-384.
    View in: PubMed
    Score: 0.154
  12. de la Rosette J, Elhilali M, Naito S, Unal D, Razvi H, Liatsikos E, Bachmann A, Tubaro A, Alivizatos G, Mak SK, Badlani G, Eltahawy E, Wong C, Telich Vidal M, Te A, d'Ancona F, Arum CJ, Gutierrez J. Clinical Research Office of the Endourological Society Global GreenLight Laser Study: Outcomes from a contemporary series of 713 patients. Int J Urol. 2015 Dec; 22(12):1124-30.
    View in: PubMed
    Score: 0.131
  13. Kaye JD, Smith AD, Badlani GH, Lee BR, Ost MC. High-energy transurethral thermotherapy with CoreTherm approaches transurethral prostate resection in outcome efficacy: a meta-analysis. J Endourol. 2008 Apr; 22(4):713-8.
    View in: PubMed
    Score: 0.079
  14. Rastinehad AR, Caplin DM, Ost MC, VanderBrink BA, Lobko I, Badlani GH, Weiss GH, Kavoussi LR, Siegel DN. Selective arterial prostatic embolization (SAPE) for refractory hematuria of prostatic origin. Urology. 2008 Feb; 71(2):181-4.
    View in: PubMed
    Score: 0.078
  15. Plante MK, Marks LS, Anderson R, Amling C, Rukstalis D, Badlani G, Getlin L, Vang E. Phase I/II examination of transurethral ethanol ablation of the prostate for the treatment of symptomatic benign prostatic hyperplasia. J Urol. 2007 Mar; 177(3):1030-5; discussion 1035.
    View in: PubMed
    Score: 0.073
  16. Shah DK, Kapoor R, Badlani GH. Experience with urethral stent explantation. J Urol. 2003 Apr; 169(4):1398-400.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.